Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01790373 · ClinicalTrials.gov registry record · NA

Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence

A NA study of HIV, sponsored by Washington University School of Medicine.

Active
Registry status
NA
Development phase
702
Enrollment target
2
Study locations

NCT01790373: Active NA study of HIV, sponsored by Washington University School of Medicine.

NCT01790373 is a NA study of HIV that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 702 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (60% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01790373, a NA study of HIV, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
702 participants
Enrollment target
2
Study locations

Study Summary

The goal of Suubi+Adherence is to examine the impact and cost associated with an innovative intervention to increase adherence to HIV treatment for HIV-infected adolescents. Multiple intervention studies by our team in Rakai and Masaka Districts of southern Uganda with AIDS-orphaned adolescents have revealed that if given an opportunity to participate in economic empowerment interventions, youth and their caregivers take full advantage of these interventions to save and invest in their future, show improvements in family financial outcomes, future aspirations, health functioning, sexual-risk taking behaviors, and mental health. The Suubi+Adherence study capitalizes on this prior work, positing that economic empowerment may be a missing, yet critical ingredient to HIV treatment adherence interventions for adolescents and young people. Suubi+Adherence incorporates an economic empowerment design, with a savings-led income generating component, to promote economic stability, and apply it to adherence to HIV treatment regimens for HIV-positive adolescents in a region of southern Uganda with the highest HIV incidence and prevalence in the country.

Primary Outcome

Adherence to HIV treatment regimen outcomes for HIV-positive adolescents, including participants' ability to access and refill prescribed HIV antiretroviral therapy and adhere to prescribed daily HIV medication routines.

Conditions Studied

Interventions

  • BEHAVIORAL Suubi+Adherence
  • BEHAVIORAL Bolstered Standard of Care

Study Locations (2)

Missouri

  • Washington University in St. Louis - St Louis

Other

  • International Center for Child Health and Asset Development - Masaka

Trial Details

FieldValue
Enrollment Target 702 participants
Start Date 2013-09-07
Est. Completion 2026-07-31
Phase NA

What the registry record for NCT01790373 still lists

NCT01790373 is an interventional study that assigns participants to a tested intervention. The registered 702 participants enrollment target is mid-sized for trials with a published cap, above the 438-participant average among 303 other HIV trials with a reported enrollment target (60% higher).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Suubi+Adherence is the first listed.

NCT01790373 reports a single indexed study location in Missouri, Other.

Frequently Asked Questions

What is clinical trial NCT01790373 about?

NCT01790373 is a clinical study titled "Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence". The goal of Suubi+Adherence is to examine the impact and cost associated with an innovative intervention to increase adherence to HIV treatment for HIV-infected adolescents. Multiple intervention studies by our team in Rakai and Masaka Districts of southern Uganda with AIDS-orphaned adolescents have...

What is the current status of trial NCT01790373?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 702 participants. The study started on 2013-09-07. Estimated completion is 2026-07-31.

What conditions does trial NCT01790373 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01790373?

The interventions under investigation include: Suubi+Adherence (BEHAVIORAL), Bolstered Standard of Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01790373?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01790373 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01790373's enrollment target sits among peer trials

702 28th of 303 higher than 276 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06027996 · 702 participants · NA

    Melodi Matrix™ in Breast Reconstruction

  • NCT05796687 · 704 participants · NA

    Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings

  • NCT06350734 · 704 participants

    Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01790373, the US trial registry maintained by the National Library of Medicine. NCT01790373 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.